1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Antacids 1.2.3 H2 Receptor Blockers 1.2.4 Proton Pump Inhibitors (PPIs) 1.2.5 Pro-kinetic Agents 1.2.6 Others 1.3 Market by Application 1.3.1 Global Gastroesophageal Reflux Disease Therapeutics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital Pharmacy 1.3.3 Drug Stores 1.3.4 General Stores 1.3.5 Supermarkets 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Gastroesophageal Reflux Disease Therapeutics Market Perspective (2016-2027) 2.2 Gastroesophageal Reflux Disease Therapeutics Growth Trends by Regions 2.2.1 Gastroesophageal Reflux Disease Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Gastroesophageal Reflux Disease Therapeutics Historic Market Share by Regions (2016-2021) 2.2.3 Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 Gastroesophageal Reflux Disease Therapeutics Industry Dynamic 2.3.1 Gastroesophageal Reflux Disease Therapeutics Market Trends 2.3.2 Gastroesophageal Reflux Disease Therapeutics Market Drivers 2.3.3 Gastroesophageal Reflux Disease Therapeutics Market Challenges 2.3.4 Gastroesophageal Reflux Disease Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Gastroesophageal Reflux Disease Therapeutics Players by Revenue 3.1.1 Global Top Gastroesophageal Reflux Disease Therapeutics Players by Revenue (2016-2021) 3.1.2 Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global Gastroesophageal Reflux Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Gastroesophageal Reflux Disease Therapeutics Revenue 3.4 Global Gastroesophageal Reflux Disease Therapeutics Market Concentration Ratio 3.4.1 Global Gastroesophageal Reflux Disease Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Gastroesophageal Reflux Disease Therapeutics Revenue in 2020 3.5 Gastroesophageal Reflux Disease Therapeutics Key Players Head office and Area Served 3.6 Key Players Gastroesophageal Reflux Disease Therapeutics Product Solution and Service 3.7 Date of Enter into Gastroesophageal Reflux Disease Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Gastroesophageal Reflux Disease Therapeutics Breakdown Data by Type 4.1 Global Gastroesophageal Reflux Disease Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Type (2022-2027) 5 Gastroesophageal Reflux Disease Therapeutics Breakdown Data by Application 5.1 Global Gastroesophageal Reflux Disease Therapeutics Historic Market Size by Application (2016-2021) 5.2 Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Gastroesophageal Reflux Disease Therapeutics Market Size (2016-2027) 6.2 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Type 6.2.1 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2016-2021) 6.2.2 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2022-2027) 6.2.3 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2016-2027) 6.3 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Application 6.3.1 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2016-2021) 6.3.2 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2022-2027) 6.3.3 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2016-2027) 6.4 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Country 6.4.1 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2016-2021) 6.4.2 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Gastroesophageal Reflux Disease Therapeutics Market Size (2016-2027) 7.2 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Type 7.2.1 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2016-2021) 7.2.2 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2022-2027) 7.2.3 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2016-2027) 7.3 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Application 7.3.1 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2016-2021) 7.3.2 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2022-2027) 7.3.3 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2016-2027) 7.4 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Country 7.4.1 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2016-2021) 7.4.2 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Type 8.2.1 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Application 8.3.1 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Region 8.4.1 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size (2016-2027) 9.2 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Type 9.2.1 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2016-2021) 9.2.2 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2022-2027) 9.2.3 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2016-2027) 9.3 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Application 9.3.1 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2016-2021) 9.3.2 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2022-2027) 9.3.3 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2016-2027) 9.4 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Country 9.4.1 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2016-2021) 9.4.2 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Type 10.2.1 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Application 10.3.1 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Country 10.4.1 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 AstraZeneca 11.1.1 AstraZeneca Company Details 11.1.2 AstraZeneca Business Overview 11.1.3 AstraZeneca Gastroesophageal Reflux Disease Therapeutics Introduction 11.1.4 AstraZeneca Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2016-2021) 11.1.5 AstraZeneca Recent Development 11.2 Eisai 11.2.1 Eisai Company Details 11.2.2 Eisai Business Overview 11.2.3 Eisai Gastroesophageal Reflux Disease Therapeutics Introduction 11.2.4 Eisai Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2016-2021) 11.2.5 Eisai Recent Development 11.3 Takeda Pharmaceutical 11.3.1 Takeda Pharmaceutical Company Details 11.3.2 Takeda Pharmaceutical Business Overview 11.3.3 Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Introduction 11.3.4 Takeda Pharmaceutical Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2016-2021) 11.3.5 Takeda Pharmaceutical Recent Development 11.4 GlaxoSmithKline 11.4.1 GlaxoSmithKline Company Details 11.4.2 GlaxoSmithKline Business Overview 11.4.3 GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Introduction 11.4.4 GlaxoSmithKline Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2016-2021) 11.4.5 GlaxoSmithKline Recent Development 11.5 Johnson & Johnson 11.5.1 Johnson & Johnson Company Details 11.5.2 Johnson & Johnson Business Overview 11.5.3 Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Introduction 11.5.4 Johnson & Johnson Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2016-2021) 11.5.5 Johnson & Johnson Recent Development 11.6 Daewoong Pharmaceutical 11.6.1 Daewoong Pharmaceutical Company Details 11.6.2 Daewoong Pharmaceutical Business Overview 11.6.3 Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Introduction 11.6.4 Daewoong Pharmaceutical Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2016-2021) 11.6.5 Daewoong Pharmaceutical Recent Development 11.7 Ironwood Pharmaceuticals 11.7.1 Ironwood Pharmaceuticals Company Details 11.7.2 Ironwood Pharmaceuticals Business Overview 11.7.3 Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Introduction 11.7.4 Ironwood Pharmaceuticals Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2016-2021) 11.7.5 Ironwood Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Antacids Table 3. Key Players of H2 Receptor Blockers Table 4. Key Players of Proton Pump Inhibitors (PPIs) Table 5. Key Players of Pro-kinetic Agents Table 6. Key Players of Others Table 7. Global Gastroesophageal Reflux Disease Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Gastroesophageal Reflux Disease Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Gastroesophageal Reflux Disease Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Regions (2016-2021) Table 11. Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Regions (2022-2027) Table 13. Gastroesophageal Reflux Disease Therapeutics Market Trends Table 14. Gastroesophageal Reflux Disease Therapeutics Market Drivers Table 15. Gastroesophageal Reflux Disease Therapeutics Market Challenges Table 16. Gastroesophageal Reflux Disease Therapeutics Market Restraints Table 17. Global Gastroesophageal Reflux Disease Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 18. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Players (2016-2021) Table 19. Global Top Gastroesophageal Reflux Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastroesophageal Reflux Disease Therapeutics as of 2020) Table 20. Ranking of Global Top Gastroesophageal Reflux Disease Therapeutics Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by Gastroesophageal Reflux Disease Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Gastroesophageal Reflux Disease Therapeutics Product Solution and Service Table 24. Date of Enter into Gastroesophageal Reflux Disease Therapeutics Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 27. Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Type (2016-2021) Table 28. Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global Gastroesophageal Reflux Disease Therapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Application (2016-2021) Table 32. Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 35. North America Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 36. North America Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 37. North America Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 38. North America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 39. North America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 41. Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 43. Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 64. AstraZeneca Company Details Table 65. AstraZeneca Business Overview Table 66. AstraZeneca Gastroesophageal Reflux Disease Therapeutics Product Table 67. AstraZeneca Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2016-2021) & (US$ Million) Table 68. AstraZeneca Recent Development Table 69. Eisai Company Details Table 70. Eisai Business Overview Table 71. Eisai Gastroesophageal Reflux Disease Therapeutics Product Table 72. Eisai Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2016-2021) & (US$ Million) Table 73. Eisai Recent Development Table 74. Takeda Pharmaceutical Company Details Table 75. Takeda Pharmaceutical Business Overview Table 76. Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Product Table 77. Takeda Pharmaceutical Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2016-2021) & (US$ Million) Table 78. Takeda Pharmaceutical Recent Development Table 79. GlaxoSmithKline Company Details Table 80. GlaxoSmithKline Business Overview Table 81. GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Product Table 82. GlaxoSmithKline Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2016-2021) & (US$ Million) Table 83. GlaxoSmithKline Recent Development Table 84. Johnson & Johnson Company Details Table 85. Johnson & Johnson Business Overview Table 86. Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Product Table 87. Johnson & Johnson Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2016-2021) & (US$ Million) Table 88. Johnson & Johnson Recent Development Table 89. Daewoong Pharmaceutical Company Details Table 90. Daewoong Pharmaceutical Business Overview Table 91. Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Product Table 92. Daewoong Pharmaceutical Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2016-2021) & (US$ Million) Table 93. Daewoong Pharmaceutical Recent Development Table 94. Ironwood Pharmaceuticals Company Details Table 95. Ironwood Pharmaceuticals Business Overview Table 96. Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Product Table 97. Ironwood Pharmaceuticals Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2016-2021) & (US$ Million) Table 98. Ironwood Pharmaceuticals Recent Development Table 99. Research Programs/Design for This Report Table 100. Key Data Information from Secondary Sources Table 101. Key Data Information from Primary Sources List of Figures Figure 1. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. Antacids Features Figure 3. H2 Receptor Blockers Features Figure 4. Proton Pump Inhibitors (PPIs) Features Figure 5. Pro-kinetic Agents Features Figure 6. Others Features Figure 7. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Application: 2020 VS 2027 Figure 8. Hospital Pharmacy Case Studies Figure 9. Drug Stores Case Studies Figure 10. General Stores Case Studies Figure 11. Supermarkets Case Studies Figure 12. Gastroesophageal Reflux Disease Therapeutics Report Years Considered Figure 13. Global Gastroesophageal Reflux Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 14. Global Gastroesophageal Reflux Disease Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Regions: 2020 VS 2027 Figure 16. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Regions (2022-2027) Figure 17. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Players in 2020 Figure 18. Global Top Gastroesophageal Reflux Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastroesophageal Reflux Disease Therapeutics as of 2020 Figure 19. The Top 10 and 5 Players Market Share by Gastroesophageal Reflux Disease Therapeutics Revenue in 2020 Figure 20. Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Type (2016-2021) Figure 21. Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Type (2022-2027) Figure 22. North America Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. North America Gastroesophageal Reflux Disease Therapeutics Market Share by Type (2016-2027) Figure 24. North America Gastroesophageal Reflux Disease Therapeutics Market Share by Application (2016-2027) Figure 25. North America Gastroesophageal Reflux Disease Therapeutics Market Share by Country (2016-2027) Figure 26. United States Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Canada Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Gastroesophageal Reflux Disease Therapeutics Market Share by Type (2016-2027) Figure 30. Europe Gastroesophageal Reflux Disease Therapeutics Market Share by Application (2016-2027) Figure 31. Europe Gastroesophageal Reflux Disease Therapeutics Market Share by Country (2016-2027) Figure 32. Germany Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. France Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. U.K. Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Italy Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Russia Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Nordic Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Share by Type (2016-2027) Figure 40. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Share by Application (2016-2027) Figure 41. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Share by Region (2016-2027) Figure 42. China Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Japan Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. South Korea Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. India Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Australia Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Gastroesophageal Reflux Disease Therapeutics Market Share by Type (2016-2027) Figure 50. Latin America Gastroesophageal Reflux Disease Therapeutics Market Share by Application (2016-2027) Figure 51. Latin America Gastroesophageal Reflux Disease Therapeutics Market Share by Country (2016-2027) Figure 52. Mexico Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Brazil Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Share by Type (2016-2027) Figure 56. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Share by Application (2016-2027) Figure 57. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Share by Country (2016-2027) Figure 58. Turkey Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Saudi Arabia Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. UAE Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. AstraZeneca Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2016-2021) Figure 62. Eisai Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2016-2021) Figure 63. Takeda Pharmaceutical Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2016-2021) Figure 64. GlaxoSmithKline Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2016-2021) Figure 65. Johnson & Johnson Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2016-2021) Figure 66. Daewoong Pharmaceutical Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2016-2021) Figure 67. Ironwood Pharmaceuticals Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2016-2021) Figure 68. Bottom-up and Top-down Approaches for This Report Figure 69. Data Triangulation Figure 70. Key Executives Interviewed

AstraZeneca Eisai Takeda Pharmaceutical GlaxoSmithKline Johnson & Johnson Daewoong Pharmaceutical Ironwood Pharmaceuticals